| Cover | Nov. 01, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Nov. 01, 2024 |
| Entity File Number | 001-41596 |
| Entity Registrant Name | Cadrenal Therapeutics, Inc. |
| Entity Central Index Key | 0001937993 |
| Entity Tax Identification Number | 88-0860746 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 822 A1A North |
| Entity Address, Address Line Two | Suite 306 |
| Entity Address, City or Town | Ponte Vedra |
| Entity Address, State or Province | FL |
| Entity Address, Postal Zip Code | 32082 |
| City Area Code | 904 |
| Local Phone Number | 300-0701 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | CVKD |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
